Literature DB >> 9120987

Vascular endothelial growth factor expression is increased in renal cell carcinoma.

D Nicol1, S I Hii, M Walsh, B Teh, L Thompson, C Kennett, D Gotley.   

Abstract

PURPOSE: To compare the expression of VEGF in renal cell carcinoma (RCC) and normal kidney.
MATERIALS AND METHODS: RT-PCR and Western blot analysis were performed on tumour and normal adjacent kidney collected from 31 patients (29 RCC and 2 oncocytomas) as well as proliferating vascular endothelial cells (VEC) in culture.
RESULTS: Expression of 3 VEGF isoforms was detected in normal renal parenchyma and all ROC by RT-PCR, but was not apparent in proliferating VEC. In 27 RCC, Western blot analysis demonstrated 3-37 fold increases in VEGF expression when compared to normal parenchyma. Immunohistochemistry demonstrated VEGF staining of both tumour cells and adjacent vascular endothelium. Normal kidney showed no staining for VEGF. In the 2 remaining RCC and both oncocytomas VEGF was not increased.
CONCLUSIONS: VEGF expression is increased in RCC and may have a paracrine effect in these tumours in stimulating angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9120987

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  29 in total

Review 1.  High-Content Assessment of Cardiac Function Using Heart-on-a-Chip Devices as Drug Screening Model.

Authors:  Genevieve Conant; Benjamin Fook Lun Lai; Rick Xing Ze Lu; Anastasia Korolj; Erika Yan Wang; Milica Radisic
Journal:  Stem Cell Rev Rep       Date:  2017-06       Impact factor: 5.739

2.  Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma.

Authors:  J W Slaton; K Inoue; P Perrotte; A K El-Naggar; D A Swanson; I J Fidler; C P Dinney
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

3.  Imaging techniques as predictive and prognostic biomarkers in renal cell carcinoma.

Authors:  Paul Nathan; Anup Vinayan
Journal:  Ther Adv Med Oncol       Date:  2013-03       Impact factor: 8.168

4.  Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer patients.

Authors:  Michalis Liontos; Eleni-Andriana Trigka; Penelope Korkolopoulou; Kimon Tzannis; Giorgos Lainakis; Konstantinos Koutsoukos; Efthymios Kostouros; Maria Lykka; Christos N Papandreou; Vassilis Karavasilis; Christos Christodoulou; Athanasios Papatsoris; Andreas Skolarikos; Ioannis Varkarakis; Ioannis Adamakis; Christos Alamanis; Konstantinos Stravodimos; Dionysios Mitropoulos; Charalambos Deliveliotis; Constantinos A Constantinidis; Angelica Saetta; Efstratios Patsouris; Meletios Α Dimopoulos; Aristotelis Bamias
Journal:  World J Urol       Date:  2016-07-09       Impact factor: 4.226

5.  Improving patient selection for adjuvant therapy in high-risk renal cell carcinoma.

Authors:  Dylan M Buller; Benjamin T Ristau
Journal:  Ann Transl Med       Date:  2019-07

6.  Antiangiogenic arming of an oncolytic vaccinia virus enhances antitumor efficacy in renal cell cancer models.

Authors:  Kilian Guse; Marta Sloniecka; Iulia Diaconu; Kathryn Ottolino-Perry; Nan Tang; Calvin Ng; Fabrice Le Boeuf; John C Bell; J Andrea McCart; Ari Ristimäki; Sari Pesonen; Vincenzo Cerullo; Akseli Hemminki
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

Review 7.  Molecular basis for the treatment of renal cell carcinoma.

Authors:  Cristina Suárez; Rafael Morales; Eva Muñoz; Jordi Rodón; Claudia M Valverde; Joan Carles
Journal:  Clin Transl Oncol       Date:  2010-01       Impact factor: 3.405

8.  Prognostic significance of platelet-derived growth factor receptor-β expression in localized clear cell renal cell carcinoma.

Authors:  Myungsun Shim; Cheryn Song; Sejun Park; Seung-Kwon Choi; Yong Mee Cho; Choung-Soo Kim; Hanjong Ahn
Journal:  J Cancer Res Clin Oncol       Date:  2015-07-28       Impact factor: 4.553

9.  Tumour vascular endothelial growth factor (VEGF) mRNA in relation to serum VEGF protein levels and tumour progression in human renal cell carcinoma.

Authors:  Börje Ljungberg; Jan Jacobsen; Stina Häggström-Rudolfssson; Torgny Rasmuson; Gudrun Lindh; Kjell Grankvist
Journal:  Urol Res       Date:  2003-09-13

10.  Combined use of COX-1 and VEGF immunohistochemistry refines the histopathologic prognosis of renal cell carcinoma.

Authors:  Wesam M Osman; Nermeen S Youssef
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.